← Evidence map

ArticleRheumatology advances in practice2026

Sustained improvements in health status and work productivity with bimekizumab in psoriatic arthritis: 2-year results from two phase 3 studies.

William Tillett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 41710044